SIRT7 and cancer: Overexpression of ELK4 can increase SIRT7 levels at specific TSG loci, maintaining low acetylation levels of H3K18 at multiple TSG promoters, thus contributing to tumorigenesis and maintaining the malignant phenotype of cancer cells, correlating with poor patient prognosis [84].